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ABSTRACT
Background: The involvement of neuropsychiatry is 
reported in 6% to 91% of Systemic Lupus Erythematosus 
(SLE) patients. It can cause fatal morbidity and mortality. 
Memory impairment is one of the most common 
symptoms of neuropsychiatry involvement. This study 
aims to find out the performance of memory test in SLE 
patients using Indonesian version of Montreal Cognitive 
Assessment (MoCA-Ina).
Method: This cross sectional study recruited 30 SLE 
patients. Cognitive abilities and patient’s memory were 
examined using Indonesian version of Montreal Cognitive 
Assessment (MoCA-Ina). Cognitive impairment was 
determined when total MoCA-Ina score was below 26. 
For memory evaluation, immediate recall or delayed 
recall impairment was determined when the patient 
failed in each memory subtests.
Results: The mean of total MoCA-Ina score 
was 24.97 (SD±3.14). Fifty percent of the SLE patients 
had cognitive impairment, with the domain involved 
being delayed recall (86.67%), attention (60%), language 
(56.67%), abstraction (53.33%), and visuo-spatial/
executive function (36.67%). Most patients (86.67%) 
could completely repeat immediate recall. While 
only 4 (13.33%) subjects could repeat delayed recall 
completely without any clue. Of the 26 SLE patients 
who failed to recall completely, 24 (92.3%) of them 
succeeded to recall completely after getting clue(s).
Conclusion: Memory impairment is the most frequent 
cognitive impairment in SLE patients, especially in 
delayed recall. By using the memory subtests of MoCA-
Ina, more than four fifth of patients with SLE  was 
detected having delayed recall memory impairment 
and almost all of them could recalled completely after 
getting clue(s). This findings indicated that the final 
step of memory process retrieval in SLE was interrupted 
while being encoded, but retention pathway were still 
intact.
Keywords: Systemic Lupus Erythematous, Memory, 
MoCA-Ina
Introduction
The involvement of neuropsychiatry in Systemic 
Lupus Erythematous (SLE) patient was reported 
in 6% to 91 % cases. It is known to cause fatal 
morbidity and mortality1, 2 American College of 
Rheumatology (ACR) described 19 manifestation 
of neuropsychiaty SLE which classified into 2 main 
group, central nervous sytem manifestation and 
peripheral nervous system manifestation.1 One of 
the neuropsychiatry manifestation implied by ACR 
was cognitive impairment, which occured in 80% 
of neuropsychiatry lupus patient.2 
According to previous study, SLE patients 
have lower cognitive ability than non-SLE. It is 
manifestated as impaired attention, visuospatial 
ability, working memory, and simple reaction 
time.1 Memory impairment is the most common 
manifestation. It is suggested that circulating 
antibody may inhibit neurotransmitter transmission 
and generate vasculopathy.1-3 As known, SLE 
mostly attacks females in their productive age. It 
would be very unfortunate if patients have memory 
impairment during their productive age, which 
would disturb their daily activities, impair their 
communication skills, and also reduce their quality 
of life.
MoCA and MMSE is the most common tools 
to assess memory and cognitive function in adult. 
MoCA has higher sensitivy in memory assessment 
than MMSE because it contained more words to 
be remembered, lesser opportunity for subjects to 
repeat, and longer time between immediate recall 
and delayed recall 4, 5 
Theory about memory impairment in SLE 
patient had been mentioned in many journals. 
However,specific study about memory performance 
in SLE patient had not been studied yet, especially 
in Indoesia. The aim of this study is describing 
memory performance in SLE patient using MoCA-
Ina in Hasan Sadikin General Hospital Bandung 
(RSHS).
Method
This quantitative-descriptive study with cross-
sectional method was conducted from September 
to November 2016. Subjects were obtained from 
Rheumatology Outpatient Clinic, Hasan Sadikin 
General Hospital, Bandung. Inclusion criteria of 
this study were age ≥ 18 years old, fullfilled at 
least 4 of 11 American College of Rheumatology 
criteria for SLE which were stated in medical 
record, came for control with no or mild symptoms 
(low disease activity). Patient would be excluded 
if they had been diagnosed with central nervous 
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system disorder before diagnosed as SLE patient. Sample was 
collected by consecutive sampling method.
Subject fullfilled inclusion and exclusion criteria will be 
assesed for their basic demographic and history of ilness, 
included  age, gender, marital status, working status, level 
of education, disease duration, and whether patient had flare 
during the examination. Cognitive ability and memory was 
assesed using Montreal Cognitive Assesment Indonesian 
version (MoCA-Ina) in RSHS Memory clinic (Klinik 
Memori RSHS). Variable used in this study was demographic 
characteristic and the result of MoCA-Ina test in SLE patient.
MoCA test assesses visuo-spatial/executive ability, 
naming, attention, language, abstraction, memory, and 
orientation. MoCA subtests assess memory aspect, included 
immediate recall and delayed recall. In immediate recall, the 
examiner will spelled out 5 words, subjects will be requested 
to repeat the words two times. In delayed recall, subjects will 
be requested to repeat the same words at the end of MoCA 
test. If subjects are able to repeat all words directly without 
any clue, they will be scored 5. If necessary, categorical 
or multiple choice clues could be given. Cut off point for 
cognitive impairment is 26.4,6
Data were analyzed using Microsoft Excel programs 
for calculating the mean, standard deviation, median, range 
for nummerical variable, and frequency (percentage) for 
categorical variable.
This study have been approved by Ethical Committee 
of Faculty Medicine of Padjadjaran University No.89/UN6.
C1.3.2/KEPK/PN/2016 and Ethical Committe of Hasan 
Sadikin General Hospital No.LB.02.01/C02/8951/VII/2016. 
Result 
We involved 30 subjects. Most subjects are female (90%) 
with mean age 35.3 years old, 70% were married and 56.7% 
subjects are not working or work as housewife. Most of 
SLE Patients (60%) are high school graduate or equals. No 
subjects had high disease activity or in flare condition. Most of 
them came without any complaint or in the remission phase. 
Disease duration range from 1 month to 16 years, with median 
duration range of 4.21 years. Some subjects included in our 
study was reported having neuropsychiatric manifestation 
during the illness, such as headcache, vertigo, stroke, and 
seizure. Characteritic of study subjects are described in Table 1.
Table 1. Characteristic of SLE Patient at RSUP Dr. Hasan Sadikin
Characteristic
N=30 Results
Age (years) 35.3±10.47*
Gender, freq(%)
Male 3 (10%)
Female 27 (90%)
Marital status, freq(%)
Married 21 (70%)
Not yet married 9 (30%)
Working, freq(%)
Working 13 (43.33%)
Not yet working 17 (56.7%)
Level of eduacation, freq(%)
Elementary school 3 (10%)
Junior high school 2 (6.7%)
High school 18 (60%)
University 7 (23.3%)
Disease duration (years) 4.21(0.08-16)**
MoCA-Ina Score 24.97 ± 3.14*
*: normal distribution data (mean ±SD); **: not normal distribution data 
(median; min-max)
MoCA-Ina test resulted 15 subjects with cognitive 
impairment (Score<26) and 15 subjects without congnitive 
impairment (50%) (Score ≥26). Cognitive impairment is 
found mostly in delayed recall test (86.7%), followed by 
attention (60%), linguistic (56,67%), abstraction (53,33%), 
and visuospatial/executive ability (36,67%). 
Most patients (86.67%) had no problem in immediate 
recall test. Meanwhile, for delayed recall test only 4 subjects 
(13.33%) are able to recall completely. We found one patients 
who unable to recall in immediate recall test but can recall 
completely without any clues in delayed recall test. (Table 2)
Table 2. Distribution of Recall Ability in SLE patient
Type of recall Able to recall  N(%)
Unable to recall
N(%)
Immediate recall 26 (86.67%) 4 (13.33%)
Delayed recall 4 (13.33%) 26 (86.67%)
 
From 26 SLE patients who unable to recall in delayed 
recall test, 24 patients (92.3%) was able to recall after given 
some clues.
Table 3 shows that memory impairment occured in all 
male patients and more often found in patients who had got 
married, working, and had longer duration of illness. We 
found memory impairment in all subjects who have low level 
education (elementary school) and all subjects who have very 
high level education (university). Memory impairment were 
also occured more often in patients with age ranged from  34 
to 45 and above 55 years old, as displayed in Table 4.
Table 3. The distribution of delayed memory impairment based 
on characteristic
Characteristic Able to recall N=4
Unable to 
recall N=26
Total
N=30
Memory 
impairment
Gender
Male 0 3 3 100 %
Female 4 23 26 85.18 %
Work
Working 0 13 13 100 %
Not Working 4 13 17 76.47 %
Marital status
Married 2 7 9 90.47 %
Not yet married 2 19 21 77.77 %
Level of education
Elementary school 0 3 3 100 %
Junior high school 1 1 2 50 %
High school 3 15 18 83.33%
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University 0 7 7 100 %
Duration of illness
< 3 years 2 11 13 84.61%
≥ 3 years 2 15 17 88.23%
Table  4. The distribution of delayed recall memory 
impaiment based on age group
Age Able to recallN=4
Unable to 
recall N=26
Total
N=30
Memory
impairment (%)
15-24 1 5 6 83.33
25-34 2 7 9 77.77
35-44 0 8 8 100
45-54 1 5 6 83.33
≥55 0 1 1 100
Discussion
Most SLE patients at Hasan Sadikin General Hospital are 
female with ratio between female and male 9:1. This finding 
is consistent to study conducted by Ortona that obtained 
the SLE ration between female and male 8-15:1. The high 
incidence rate in female is possibly caused by the influence of 
sex hormon, mainly estrogen. Previous studies have reported 
that major SLE patients were female in reproductive age. This 
fact is suitable with the result of our study7
Seventeen SLE patients does not work (56.67%) or stop 
working after being diagnosed as SLE. Study conducted 
by Panopalis,et al. mentioned that SLE patients were not 
able to work due to 2 factors, neurocognition disorder and 
depression.8  Study conducted by Utset,et al  also mentioned 
that 31% SLE patient from 6 medical institution in United 
States of America were unable to work.9 Further, study 
conducted by Apenzeler,et al explained that the reasons made 
SLE patients unable to work were fatigue, pain, and coginitive 
impairment.10
Fifteen SLE patients (50%) have mild congnitive 
impairment with MoCA-Ina total score <26, the most impaired 
domain is delayed recall.  Study conducted by Mahdavi,et al 
in Iran showed a lower prevalence of cognitive impairment in 
SLE patient, which was about 33.3%, with domain impairment 
in orientation, linguistic, and delayed recall.11 Hawro,et al 
study with Mini Mental State Examination (MMSE) and 
Clock Drawing Test (CDT) in 52 SLE patients, found only 
5 patients (9.62%) had cognitive impairment (MMSE score 
<27).12 Characteristics of cognitive impairment in SLE 
patients denoted by decreased concentration ability, memory, 
learning, verbal or non-verbal fluency, language, visuospatial 
ability and motoric and is probably caused by damage on 
fronto-subcortican circuit.1 The various result in this cognitive 
assessmet could have been caused by the differences in age 
and level of education of the subjects, as well as the measuring 
tools and cut off  point used. 
Memory impairment is one of the most common cognitive 
symptomps.3 Kozora conducted Paced Auditory Serial 
Addition Test (PASAT) in 73 SLE patients and found that 21 
patients (29%) have PASAT total T-scores below 40 which 
indicated working memory impairment.13 Process of memory 
formation  consisted of encoding, retention or storage,  and 
retrieving information. Encoding and retrieving process 
occured in prefrontal cortex, meanwhile retention process 
occured in hippocampus.14
For the MoCA-Ina interpretation, if subjects enable 
to recall after giving clues either a categorical or multiple 
choice clues, it indicates that encoding and storage process 
are decent, but retrieving process is impaired. This process 
is quite important for a person in making decision, working, 
and interacting with others. 15 Most of our subjects could 
recall after the clues which indicating that the disturbance in 
memory processing is in the retrieval phase. The finding is 
quite similar to the findings in study conducted by Paran, et al 
in which memory performance of SLE patients was worse than 
control when tested using  Rey Auditory Verbal Learning Test 
(RAVLT). The shortage was especially noticeable in delayed 
recall part and recognition part which indicated retrieval 
process impairment. The symptoms caused by this memory 
impairment pattern is reported similar with the symptoms of 
patients experienced frontal lobes impairment.15
De Melo, et al. reported that memory impairment of SLE 
patients was more frequently occured in older patient and was 
not influenced by the level of education.16 Whereas, several 
studies showed that demographic factors, disease duration, 
and disease activity did not influence memory impairment in 
SLE patient.15-17 The report is  accordance with the result of our 
study which memory impairment was found inconsistent with 
the level of education and patients’ age. Works, marriage, and 
duration of illness seems have slight influences on memory 
impairment of SLE patients. Memory impairment might be 
caused by many other factors in addition to demographic 
characteristics, such as drugs’ effects, psychological condition 
during examination, SLEDAI score, and the level of circulating 
antibody. Unfortunately, these factors were not assesed in this 
study. 
Memory impairment in SLE patient is affected by the 
existance of autoantibody that attacked the N-Methyl-D-
Aspartate (NMDA) receptor and arteritis mechanism.15,18 
Several antibodies that might have contribution in memory 
impairment are anti-DNA and anti-NMDA receptor subtype 
2 (anti-NR2). Anti-DNA and anti-NR2 antibody will bound to 
NR2A and NR2B subunit of NMDA receptor. When antibodies 
bound to NMDA receptor, the cells are stimulated to apoptosis, 
thus the transmission of neutransmitter will not be occured.2, 
3 Other study showed that memory impairment in SLE can be 
caused by vasculopathy, particularly on microvascularization 
in prefrontal lobes. Vascular endothelial wall is damaged 
by chronic inflamation caused by the deposition of immune 
complexes. The inflammation would reduced distribution of 
oxygenated and nutrition-rich blood to the brain which cause 
cerebral ischemia and memory impairment. Vasculopathy that 
occured in fronto-subcortical circuit may result in cognitive 
and memory impairment. 18, 19
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The limitation of this study is the limited sample available, 
therefore conducting analytical study will not be possible. 
Moreover, the cross-sectional design can not explain the 
causality association between variables. In addition, other 
factors that might affect cognitive and memory impairment, 
such as the drugs effects, psychological condition, SLEDAI 
score, and the existence or the level of spesific autoantibody 
were not analyzed due to some limitations.
Conclusion
About 50% of SLE patients have cognitive impairment with 
delayed recall being the most frequently impaired domain 
followed respectively by attention, linguistic, abstraction, and 
visuospatial/executive ability. Most subjects (92.3%) were 
able to recall completely after given clues which indicated that 
the disturbance of memory process was occured in retrieval 
process. 
It is necessary to conduct further study with larger samples 
along with analyzing the factors that contribute to cognitive 
and memory impairment in SLE patient. Moreover, cognition 
and memory assesment should be done intergratedly in order 
to do early prevention for cognitive impairment so that the 
quality of life of SLE patient could be improved. MoCA-Ina 
examination is a promising modalities used to assesed cognitive 
and memory impairment in SLE patients which have similar 
quality as spesific complex memory neuropsychological test. 
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